109 results
SC TO-C
EX-99.2
CTIC
CTI BioPharma Corp
10 May 23
Information about tender offer
5:01pm
for Sobi Differentiated asset by clinical data and mode of action in an area of unmet medical need Highly skilled workforce in the area of Haemato …
Differentiated asset by clinical data and mode of action in an area of unmet medical need Highly skilled workforce in the area of Haemato-Oncology Significant
SC14D9C
EX-99.4
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
2:02pm
a highly talented and innovative workforce it intends to leverage for the success of the combined company.
What happens to my CTI stock options and will my
SC14D9C
EX-99.1
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
2:02pm
talented, passionate and innovative minds in hematology-oncology, a workforce they intend to leverage for the success of the combined company.
Next
424B5
m3dqefc
14 Feb 20
Prospectus supplement for primary offering
8:14am
424B5
6wih2hrbxjnb
15 Nov 19
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
6x337d
2 May 19
CTI BioPharma Reports First Quarter 2019 Financial Results
4:26pm
8-K
EX-99.1
wgvh 70bu
13 Mar 19
CTI BioPharma Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights
4:17pm
8-K
EX-1
arxqbqox vb1oj
3 Jan 19
Regulation FD Disclosure
4:37pm
8-K
EX-99.1
nlk1pvfyq2
18 Dec 18
CTI BioPharma Provides Program Update Following Regulatory Feedback from the U.S. FDA on Pacritinib Development
4:49pm
8-K
EX-99.1
yi3kf8mg
13 Dec 18
CTI BioPharma Announces Restructuring Plan
5:15pm
8-K
7nyp ez34sq4o
13 Dec 18
CTI BioPharma Announces Restructuring Plan
5:15pm